摘要 |
The invention relates to an anti-HSV antibody as defined in the claims, a pharmaceutical composition comprising of an effective amount of the said antibody, an expression vector comprising of a nucleotide sequence which encodes the said antibody, a host cell comprising of the said nucleotide sequence, a hybridoma cell capable of producing the said antibody and the use of the said antibody as a drug, in particular to use for the manufacture of a drug for the prophylactical or therapeutical treatment of HSV-associated diseases in a subject; as defined in the claims. |
申请人 |
UNIVERSITAET DUISBURG-ESSEN;RHEINISCHE FRIEDRICH-WILHELMS-UNIVERSITAET BONN;ROGGENDORF, MICHAEL;EIS-HUEBINGER, ANNA-MARIA;KRAUSS, JUERGEN;SCHNEWEIS, KARL EDUARD;ARNDT, MICHAELA;KRAWCZYK, ADALBERT;EXNER, EVELYN;DAEUMER, MARTIN |
发明人 |
ROGGENDORF, MICHAEL;EIS-HUEBINGER, ANNA-MARIA;KRAUSS, JUERGEN;SCHNEWEIS, KARL EDUARD;ARNDT, MICHAELA;KRAWCZYK, ADALBERT;EXNER, EVELYN;DAEUMER, MARTIN |